Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
PharmX Technologies ( (AU:PHX) ) has issued an announcement.
PharmX Technologies Limited has announced a proposed placement of up to 59,950,679 ordinary fully paid shares on the Australian Securities Exchange. The new securities are expected to be issued on 25 February 2026, signaling a significant capital-raising initiative that could provide additional funding flexibility and potentially dilute existing shareholders.
The company has lodged an Appendix 3B detailing the proposed issue, confirming its application for quotation of the new shares in line with ASX Listing Rules. This move may strengthen PharmX Technologies’ balance sheet and support future corporate or operational activities, while investors will watch closely for further disclosure on pricing, use of proceeds, and resulting ownership changes.
More about PharmX Technologies
PharmX Technologies Limited is an Australia-listed company trading under the ASX code PHX. The firm operates in the technology and healthcare-related sector, with its shares issued as ordinary fully paid securities on the Australian Securities Exchange.
Average Trading Volume: 652,515
Technical Sentiment Signal: Buy
Current Market Cap: A$83.93M
For a thorough assessment of PHX stock, go to TipRanks’ Stock Analysis page.